Welcome to our dedicated page for Embecta SEC filings (Ticker: EMBC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading 250 pages of medical-device jargon to find out how a 300-unit insulin patch pump affects margins? Embecta’s SEC filings can feel as technical as its pen needles. From intricate FDA disclosures to segment-level cost data, locating what truly moves EMBC’s share price is a challenge.
Stock Titan solves that problem. Our AI turns every Embecta quarterly earnings report 10-Q filing, Embecta annual report 10-K simplified, and Embecta 8-K material events explained into clear language you can skim in minutes. Need to monitor Embecta insider trading Form 4 transactions? We stream Embecta Form 4 insider transactions real-time, flagging executive buys and sells the moment they hit EDGAR. Want the numbers behind the new patch-pump production line? Our platform highlights R&D spend, manufacturing gross margin shifts, and litigation risks—no manual page-flip required.
Here’s what you’ll unlock:
- AI-powered summaries that spotlight pump-technology milestones and contract-manufacturing revenue
- Instant alerts on Embecta executive stock transactions Form 4 and upcoming Embecta proxy statement executive compensation details
- Side-by-side charts for Embecta earnings report filing analysis—track insulin-delivery segment trends quarter over quarter
Embecta Corp. Schedule 13G disclosure shows passive beneficial ownership positions by American Century entities and Stowers Institute in Embecta common stock. American Century Investment Management, American Century Companies and Stowers Institute report aggregate beneficial ownership of 5,195,948 shares (8.9% of the class), while American Century Capital Portfolios reports 3,460,379 shares (5.9% of the class). The filing states these securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing also notes that ACIM acts as investment adviser to accounts holding these securities and that no single ACIM client owns more than 5% of the class.
Jean Casner, Chief Human Resources Officer of Embecta Corp. (EMBC), reported a transaction on 08/09/2025 affecting her direct holdings of the issuer's common stock. The filing shows 916 shares were withheld in connection with the vesting of restricted stock units, with a reported price of $12.28 per share. After the transaction the reporting person held 48,798.926 shares beneficially in a direct ownership form. The filing includes an explanation that the withheld shares satisfied withholding tax obligations and that the reported share total includes stock dividends.
The form is signed by a power of attorney on behalf of the reporting person and incorporates a referenced power of attorney dated July 19, 2023.
Embecta Corp. (EMBC) Q3 FY2025 highlights: For the three months ended June 30, 2025 revenues were $295.5 million versus $272.5 million a year earlier and net income was $45.5 million versus $14.7 million. Diluted EPS was $0.78 versus $0.25. For the nine months ended June 30, 2025 revenues were $816.4 million versus $837.0 million and net income was $69.0 million versus $63.7 million.
Key operating and balance sheet items: Gross profit for the quarter was $197.1 million; operating income was $94.0 million. Cash and equivalents were $230.6 million at June 30, 2025. Long-term debt (net of discounts and issuance costs) was $1,458.8 million and total principal outstanding was $1,489.1 million. Total assets were $1,157.3 million and total equity was negative $669.6 million.
- Restructuring: Patch Pump charges totaled $34.3 million and a 2025 restructuring plan added $3.5 million during the nine months.
- Cash flow: Net cash provided by operating activities was $107.7 million for the nine months.
- Receivables: $26.2 million of receivables were sold during the period.
Embecta Corp. furnished a press release announcing results for the quarter ended June 30, 2025. The company submitted an 8-K to share this update and included the full press release as Exhibit 99.1. The filing notes the update relates to results of operations and financial condition. Shares trade on Nasdaq under EMBC.
FAQ
What is the current stock price of Embecta (EMBC)?
What is the market cap of Embecta (EMBC)?
